Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesIs Short-term Celecoxib Intervention A Effective Method For Preventing Gastric Carcinogenesis
ScienceDaily, 10/29/09
Since the isolation and culture of Helicobacter pylori in 1983, this bacterium has become accepted as an important human pathogen for the development of gastritis, peptic ulcer, and gastric cancer. Cyclooxgenase–2 is a prostaglandin–synthesizing enzyme. Elevated expression of COX–2 is observed in a wide variety of human malignancies, including gastric cancer.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Polymer therapeutic protects gut from radiation damage, infection after cancer treatment
EurekAlert, 12/04/09
Cigarette smoking increases colorectal cancer risk
ScienceDaily, 12/04/09
Hepatitis C drug fights virus in new way
Reuters, 12/04/09
Sponsor
Article Search
Sponsor